How can iPS cells be used?
|2008||Based on the promise of iPS cell technology, CDI and SCP merge into a single company, Cellular Dynamics International.|
|2004, 2005||Cellular Dynamics International (CDI) and its sister company, Stem Cell Products, Inc. (SCP), were formed based on hES cell technology and IP licensed from the Wisconsin Alumni Research Foundation (WARF).|
CDI founder Dr. James Thomson reported the derivation of human embryonic stem (ES) cells. Their ability to generate any cell in the body revolutionized thinking in the field of regenerative medicine. Starting with human ES cells, CDI founder Dr. Timothy Kamp was able to differentiate them into human cardiomyocytes, generating a cell type that was previously very difficult to obtain from primary cell sources. From 1998 to present many groups have been refining differentiation protocols and generating new cell types from human ES cells.
The idea of cell reprogramming began in 1997 with Dolly the cloned sheep. Dolly showed it was possible to have a differentiated adult cell revert back to a blank slate cell and give rise to all the different cell types in an organism.